Skip to main content

Genentech Opportunities

Genentech seeks academic and industry partners across multiple therapeutic areas to develop transformative medicines, leveraging both established and emerging therapeutic modalities to address significant unmet medical needs.

Overview

  • Partnership opportunities across multiple therapeutic areas and technology platforms
  • Focused on transformative science addressing diseases with significant unmet needs
  • Interest in both established and newer therapeutic modalities (siRNAs, ASOs, cell therapies, gene silencing)
  • Strong industry track record with 18+ oncology medicines introduced since 2011

Priority Areas

  • Cardiovascular, Renal & Metabolic Disease: Uncontrolled hypertension, obesity, MASH, MI/stroke prevention, cardiomyopathies, SPAF
  • Oncology & Hematology: Breast cancer, lung cancer, malignant hematology, colorectal cancer, prostate cancer, bladder cancer
  • Immunology: Gastroenterology, respiratory, rheumatology targets (innate, adaptive, fibrosis, tolerance, tissue regeneration)
    Infectious Diseases: Hepatitis B, multidrug-resistant gram-negative bacterial infections
  • Neurology: Neurodegenerative diseases, neuroinflammation, neuromuscular diseases, other CNS indications
  • Ophthalmology: Retinal diseases, long-acting ocular drug delivery, glaucoma, dry eye disease
  • Research Technologies: New mechanisms of action, targeted delivery, genomic medicine platforms, novel target discovery
  • Digital & Data: Real-world data, advanced analytics, digital tools and platforms for AI model training

Eligibility & Requirements

  • Proposals must contain non-confidential information only
  • Technologies should align with specific therapeutic area priorities listed above
  • Innovation addressing unmet medical needs in targeted disease areas
  • Solutions that complement Genentech's existing portfolio and technological capabilities

Timeline

Applications accepted on a rolling basis

How to Submit

Please note: Full RFP is attached in the "More Information" section of this page. Faculty and researchers interested in applying for these opportunities based on technologies developed or disclosed at Vanderbilt must submit their proposals through the CTTC.